{"id":3570,"date":"2022-11-07T13:25:17","date_gmt":"2022-11-07T11:25:17","guid":{"rendered":"https:\/\/staging.iasispharma.com\/en\/?p=3570"},"modified":"2026-10-30T13:29:47","modified_gmt":"2026-10-30T11:29:47","slug":"iasis-pharma-participation-in-the-18th-panhellenic-conference-of-dermatology-venereology","status":"publish","type":"post","link":"https:\/\/iasispharma.com\/en\/all-articles\/iasis-pharma-participation-in-the-18th-panhellenic-conference-of-dermatology-venereology\/","title":{"rendered":"IASIS PHARMA PARTICIPATION IN THE 18th PANHELLENIC CONFERENCE OF DERMATOLOGY &#038; VENEREOLOGY"},"content":{"rendered":"<p><strong>INTERCONTINENTAL Hotel<br \/>\nAthens, 03-06\/11\/2022<\/strong><\/p>\n<p><strong>IASIS PHARMA<\/strong> participated in the 18<sup>th<\/sup> Panhellenic Conference of Dermatology &amp; Venereology which took place on November 03-06, 2022 at the &#8220;Intercontinental&#8221; Hotel in Athens.<\/p>\n<p>At <strong>IASIS PHARMA<\/strong> exhibition stand, the <strong><u>new<\/u><\/strong> &amp; <strong><u>unique<\/u><\/strong> <strong>Isotroin 30mg<\/strong> was presented for the first time. <strong>Isotroin 30mg<\/strong> completes the range of the other Isotroin contents (10mg, 20mg &amp; the also unique 40mg).<\/p>\n<p><strong>Isotroin<\/strong><sup>\u00ae<\/sup>\/Isotretinoin is indicated for the severe forms of Acne that are resistant to treatment with systemic antibiotics and topical therapy.<\/p>\n<p>The following products were also presented:<br \/>\n<strong>Modiwart<\/strong><sup>\u00ae<\/sup><strong>\/Imiquimod<\/strong>, an innovative modifier of the immune response system indicated for the treatment of: External Genital Warts, Superficial Basal Cell Carcinoma and Actinic keratosis.<\/p>\n<p><strong>Combi<\/strong><sup>\u00ae<\/sup>, a combination of fluprednidene+miconazole cream for the treatment of Inflammatory Dermatomycoses such as Fungal Vaginitis (or Vaginal Candidiasis).<\/p>\n<p>&nbsp;<\/p>\n<p><img decoding=\"async\" class=\"alignnone wp-image-3566\" src=\"https:\/\/iasispharma.com\/wp-content\/uploads\/2022\/11\/IMG_20221103_143921_1-225x300.jpg\" alt=\"img_20221103_143921_1\" width=\"375\" height=\"500\" srcset=\"https:\/\/iasispharma.com\/wp-content\/uploads\/2022\/11\/IMG_20221103_143921_1-120x160.jpg 120w, https:\/\/iasispharma.com\/wp-content\/uploads\/2022\/11\/IMG_20221103_143921_1-200x267.jpg 200w, https:\/\/iasispharma.com\/wp-content\/uploads\/2022\/11\/IMG_20221103_143921_1-225x300.jpg 225w, https:\/\/iasispharma.com\/wp-content\/uploads\/2022\/11\/IMG_20221103_143921_1-400x533.jpg 400w, https:\/\/iasispharma.com\/wp-content\/uploads\/2022\/11\/IMG_20221103_143921_1-500x667.jpg 500w, https:\/\/iasispharma.com\/wp-content\/uploads\/2022\/11\/IMG_20221103_143921_1-600x800.jpg 600w, https:\/\/iasispharma.com\/wp-content\/uploads\/2022\/11\/IMG_20221103_143921_1-700x933.jpg 700w, https:\/\/iasispharma.com\/wp-content\/uploads\/2022\/11\/IMG_20221103_143921_1-768x1024.jpg 768w, https:\/\/iasispharma.com\/wp-content\/uploads\/2022\/11\/IMG_20221103_143921_1-800x1067.jpg 800w, https:\/\/iasispharma.com\/wp-content\/uploads\/2022\/11\/IMG_20221103_143921_1-1200x1600.jpg 1200w, https:\/\/iasispharma.com\/wp-content\/uploads\/2022\/11\/IMG_20221103_143921_1-scaled.jpg 1920w\" sizes=\"(max-width: 375px) 100vw, 375px\" \/><\/p>\n","protected":false},"excerpt":{"rendered":"<p>INTERCONTINENTAL Hotel Athens, 03-06\/11\/2022 IASIS PHARMA participated in the 18th Panhellenic Conference of Dermatology &amp; Venereology which took place on November 03-06, 2022 at the &#8220;Intercontinental&#8221; Hotel in Athens. At IASIS PHARMA exhibition stand, the new &amp; unique Isotroin 30mg was presented for the first time. Isotroin 30mg completes the range of the other Isotroin  [&#8230;]<\/p>\n","protected":false},"author":5,"featured_media":0,"comment_status":"closed","ping_status":"open","sticky":false,"template":"","format":"standard","meta":{"_jetpack_newsletter_access":"","_jetpack_dont_email_post_to_subs":true,"_jetpack_newsletter_tier_id":0,"_jetpack_memberships_contains_paywalled_content":false,"_jetpack_hide_featured_image":false,"_jetpack_featured_image_duplicate_dismissed":0,"_jetpack_feature_clip_id":0,"_jetpack_memberships_contains_paid_content":false,"footnotes":"","jetpack_publicize_message":"","jetpack_publicize_feature_enabled":true,"jetpack_social_post_already_shared":true,"jetpack_social_options":{"image_generator_settings":{"template":"highway","default_image_id":0,"font":"","enabled":false},"version":2},"jetpack_post_was_ever_published":false},"categories":[33,157],"tags":[],"class_list":["post-3570","post","type-post","status-publish","format-standard","hentry","category-all-articles","category-press-room-en"],"jetpack_publicize_connections":[],"jetpack_sharing_enabled":true,"jetpack_shortlink":"https:\/\/wp.me\/p7HJeP-VA","jetpack_featured_media_url":"","_links":{"self":[{"href":"https:\/\/iasispharma.com\/en\/wp-json\/wp\/v2\/posts\/3570","targetHints":{"allow":["GET"]}}],"collection":[{"href":"https:\/\/iasispharma.com\/en\/wp-json\/wp\/v2\/posts"}],"about":[{"href":"https:\/\/iasispharma.com\/en\/wp-json\/wp\/v2\/types\/post"}],"author":[{"embeddable":true,"href":"https:\/\/iasispharma.com\/en\/wp-json\/wp\/v2\/users\/5"}],"replies":[{"embeddable":true,"href":"https:\/\/iasispharma.com\/en\/wp-json\/wp\/v2\/comments?post=3570"}],"version-history":[{"count":4,"href":"https:\/\/iasispharma.com\/en\/wp-json\/wp\/v2\/posts\/3570\/revisions"}],"predecessor-version":[{"id":3574,"href":"https:\/\/iasispharma.com\/en\/wp-json\/wp\/v2\/posts\/3570\/revisions\/3574"}],"wp:attachment":[{"href":"https:\/\/iasispharma.com\/en\/wp-json\/wp\/v2\/media?parent=3570"}],"wp:term":[{"taxonomy":"category","embeddable":true,"href":"https:\/\/iasispharma.com\/en\/wp-json\/wp\/v2\/categories?post=3570"},{"taxonomy":"post_tag","embeddable":true,"href":"https:\/\/iasispharma.com\/en\/wp-json\/wp\/v2\/tags?post=3570"}],"curies":[{"name":"wp","href":"https:\/\/api.w.org\/{rel}","templated":true}]}}